XML 64 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
6 Months Ended
Jun. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
STOCK-BASED COMPENSATION
Employee Share Purchase Plan
At our 2013 Annual Meeting of Shareholders, which was held on May 9, 2013, our shareholders approved an amendment to our Employee Share Purchase Plan to increase the number of shares of our common stock reserved for issuance under the plan from 3,700,000 to 3,950,000.
1995 Stock Incentive Plan and 1995 Supplemental Stock Incentive Plan
Also at our 2013 Annual Meeting of Shareholders, our shareholders approved an amendment to our 1995 Stock Incentive Plan (the “1995 Plan”) to increase the number of shares of our common stock reserved for issuance under the plan from 10,750,000 to 11,000,000. Our 1995 Supplemental Stock Incentive Plan (the “1995 Supplemental Plan”) allows for the issuance of a maximum of 500,000 shares of our common stock.
The following table sets forth certain information regarding the 1995 Plan and the 1995 Supplemental Plan:
 
June 30,
2013
Shares available for grant
2,331,500

Shares of common stock reserved for issuance
3,910,876


The following table sets forth certain information regarding all options outstanding and exercisable:
 
June 30, 2013
 
Options
Outstanding
 
Options
Exercisable
Number
767,869

 
199,785

Weighted average exercise price
$
39.38

 
$
28.71

Aggregate intrinsic value
$ 25.8 million

 
$ 8.9 million

Weighted average remaining contractual term
5.0 years

 
3.9 years


The following table sets forth certain information regarding all RSUs nonvested and expected to vest:
 
June 30, 2013
 
RSUs Nonvested
 
RSUs Expected
to Vest
Number
811,509

 
718,887

Weighted average grant date per share fair value
$
43.13

 
$
42.67

Aggregate intrinsic value
$ 59.3 million

 
$ 52.5 million

Weighted average remaining term to vest
1.4 years

 
1.4 years


As of June 30, 2013, unrecognized stock-based compensation related to outstanding, but unvested stock options and RSUs was $35.5 million, which will be recognized over the weighted average remaining vesting period of 1.8 years.
Stock-Based Compensation Expense
Our stock-based compensation expense was included in our Consolidated Statements of Operations as follows (in thousands):
 
Thirteen Weeks Ended
 
Twenty-Six Weeks Ended
 
June 30,
2013
 
July 1,
2012
 
June 30,
2013
 
July 1,
2012
Cost of sales
$
616

 
$
365

 
$
1,211

 
$
864

Research and development
545

 
443

 
1,076

 
957

Selling, general and administrative
3,187

 
2,255

 
6,425

 
4,855

Total stock-based compensation
$
4,348

 
$
3,063

 
$
8,712

 
$
6,676